#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cold type haemolytic anaemia Duchenne muscular dystrophy gene carrier Hypergammaglobulinaemia benign monoclonal Hereditary spastic paraplegia Atopic keratoconjunctivitis Ovarian epithelial cancer Neovascular age-related macular degeneration Cerebellar ataxia Malignant neoplasm of choroid Colitis ulcerative Retinitis pigmentosa Oesophageal squamous cell carcinoma stage II Bulbospinal muscular atrophy congenital Immune-mediated myasthenia gravis Post transplant lymphoproliferative disorder More trials…

    Learn about Rare Diseases

    Rett syndrome Fabry’s disease – Diagnostics Mantle cell lymphoma stage IV – Basic Information Pelizaeus-Merzbacher disease – Basic Information Paroxysmal nocturnal haemoglobinuria – Treatment Osteosarcoma metastatic – Trials in Disease Encephalitis autoimmune – Diagnostics Mucous membrane pemphigoid Pituitary-dependent Cushing’s syndrome – Trials in Disease Hereditary motor and sensory neuropathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apraglutide Sacubitril Valsartan Eplontersen Izorlisib Mesilate Bidridistrogene Xeboparvovec Codeine Phosphate Hemihydrate Pal1-15 Acetate Mps-214 Fosphenytoin Sodium Bexmarilimab Brivaracetam Xtmab-16 Lenograstim 18F-Fludarabine Artemisia Vulgaris (312) Danazol Acp-204 Tartrate Cilastatin Vitamin A Bp Mometasone More therapies…

    Learn about Your Condition

    Systemic mastocytosis Hypothyroidism Biotinidase deficiency Normal pressure hydrocephalus Rhinitis allergic Intestinal infarction Systemic lupus erythematosus Nicotine dependence Malignant melanoma stage III C3 glomerulopathy Diabetic gastroparesis Vascular dementia Fibrosarcoma Post-traumatic headache Myocardial ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Pemetrexed Disodium
    • BNT327
    • Carboplatin
    Belgium Bulgaria France Germany Hungary Italy +3

  • Study on Cemiplimab and OSE2101 for Maintenance Therapy in Patients with ctDNA Positive Non-Small Cell Lung Cancer (NSCLC)

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    Italy

  • Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Bevacizumab
    • Carboplatin
    France

  • Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Budigalimab
    • Carboplatin
    • Cisplatin
    Belgium France Germany Italy Poland Romania +1

  • Study on Treating Advanced Non-Small Cell Lung Cancer with Cemiplimab and Chemotherapy Based on Blood Tumor DNA Levels

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cemiplimab
    • Paclitaxel
    Spain

  • Study comparing Rilvegostomig plus chemotherapy versus Pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rilvegostomig
    • Carboplatin
    • Cisplatin
    Belgium France Germany Hungary Italy The Netherlands +2
Previous Page
1 … 6 7 8 9 10 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!